US 11154574
Tumor infiltrating lymphocytes and methods of therapy
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11154574 (Tumor infiltrating lymphocytes and methods of therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/52, A61K2239/57